NCT06981078Phase 2Active not recruiting

A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD

Study sponsor: Upstream Bio Inc. · UPB

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2027-10Estimated
Enrollment · participants666Estimated
Source updated2026-07-20Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Primary completion date changed

Before: Apr 2028. After: Oct 2027.

Check registry source

· 1 field changed

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview